Literature DB >> 17348080

Analyzing survival curves at a fixed point in time.

John P Klein1, Brent Logan, Mette Harhoff, Per Kragh Andersen.   

Abstract

A common problem encountered in many medical applications is the comparison of survival curves. Often, rather than comparison of the entire survival curves, interest is focused on the comparison at a fixed point in time. In most cases, the naive test based on a difference in the estimates of survival is used for this comparison. In this note, we examine the performance of alternatives to the naive test. These include tests based on a number of transformations of the survival function and a test based on a generalized linear model for pseudo-observations. The type I errors and power of these tests for a variety of sample sizes are compared by a Monte Carlo study. We also discuss how these tests may be extended to situations where the data are stratified. The pseudo-value approach is also applicable in more detailed regression analysis of the survival probability at a fixed point in time. The methods are illustrated on a study comparing survival for autologous and allogeneic bone marrow transplants. Copyright (c) 2007 John Wiley & Sons, Ltd.

Mesh:

Year:  2007        PMID: 17348080     DOI: 10.1002/sim.2864

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  86 in total

1.  Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

Authors:  Maurizio Aricò; Martin Schrappe; Stephen P Hunger; William L Carroll; Valentino Conter; Stefania Galimberti; Atsushi Manabe; Vaskar Saha; André Baruchel; Kim Vettenranta; Keizo Horibe; Yves Benoit; Rob Pieters; Gabriele Escherich; Lewis B Silverman; Ching-Hon Pui; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2010-09-27       Impact factor: 44.544

2.  SAS and R functions to compute pseudo-values for censored data regression.

Authors:  John P Klein; Mette Gerster; Per Kragh Andersen; Sergey Tarima; Maja Pohar Perme
Journal:  Comput Methods Programs Biomed       Date:  2008-01-15       Impact factor: 5.428

3.  Methods for equivalence and noninferiority testing.

Authors:  Gisela Tunes da Silva; Brent R Logan; John P Klein
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

4.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Authors:  Madan Jagasia; Mukta Arora; Mary E D Flowers; Nelson J Chao; Philip L McCarthy; Corey S Cutler; Alvaro Urbano-Ispizua; Steven Z Pavletic; Michael D Haagenson; Mei-Jie Zhang; Joseph H Antin; Brian J Bolwell; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Robert Peter Gale; Vikas Gupta; Stephanie J Lee; Mark Litzow; Daniel J Weisdorf; Mary M Horowitz; Theresa Hahn
Journal:  Blood       Date:  2011-10-18       Impact factor: 22.113

5.  No association between q-angle and foot posture with running-related injuries: a 10 week prospective follow-up study.

Authors:  Daniel Ramskov; M L Jensen; K Obling; R O Nielsen; E T Parner; S Rasmussen
Journal:  Int J Sports Phys Ther       Date:  2013-08

6.  Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients.

Authors:  Khoan Vu; Shivaprasad Manjappa; John F DiPersio; Feng Gao; Peter Westervelt; Ravi Vij; Keith E Stockerl-Goldstein; Geoffrey L Uy; Camille N Abboud; Mark A Schroeder; Todd A Fehniger; Amanda F Cashen; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

7.  Milestone Survival: A Potential Intermediate Endpoint for Immune Checkpoint Inhibitors.

Authors:  Tai-Tsang Chen
Journal:  J Natl Cancer Inst       Date:  2015-06-25       Impact factor: 13.506

8.  Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.

Authors:  S Iacobelli; L C de Wreede; S Schönland; B Björkstrand; U Hegenbart; A Gruber; H Greinix; L Volin; F Narni; A M Carella; M Beksac; A Bosi; G Milone; P Corradini; K Friberg; A van Biezen; H Goldschmidt; T de Witte; C Morris; D Niederwieser; L Garderet; N Kröger; G Gahrton
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

9.  Temporal Prediction of Future State Occupation in a Multistate Model from High-Dimensional Baseline Covariates via Pseudo-Value Regression.

Authors:  Sandipan Dutta; Susmita Datta; Somnath Datta
Journal:  J Stat Comput Simul       Date:  2016-12-20       Impact factor: 1.424

10.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.